149 related articles for article (PubMed ID: 28759773)
1. High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway.
Barlinn R; Rollag H; Trogstad L; Vainio K; Basset C; Magnus P; Dudman SG
J Clin Virol; 2017 Sep; 94():57-62. PubMed ID: 28759773
[TBL] [Abstract][Full Text] [Related]
2. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
3. Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: a case-control study within 35 940 pregnant women.
Sarfraz AA; Samuelsen SO; Bruu AL; Jenum PA; Eskild A
BJOG; 2009 Oct; 116(11):1492-8. PubMed ID: 19769750
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 DNAemia in pregnant women in relation to perinatal death: A nested case-control study within a large population-based pregnancy cohort.
Barlinn R; Trogstad L; Rollag H; Frøen F; Magnus P; Dudman SG
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):856-864. PubMed ID: 31925774
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 seroconversion in a cohort of human immunodeficiency virus-infected patients.
Azevedo KM; Setúbal S; Camacho LA; Garcia Rde C; Siqueira MM; Pereira RF; de Oliveira SA
Mem Inst Oswaldo Cruz; 2012 May; 107(3):356-61. PubMed ID: 22510831
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses.
de Haan TR; Beersma MF; Claas EC; Oepkes D; Kroes AC; Walther FJ
Fetal Diagn Ther; 2007; 22(1):55-62. PubMed ID: 17003557
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
12. The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.
Adam O; Makkawi T; Reber U; Kirberg H; Eis-Hübinger AM
Epidemiol Infect; 2015 Jan; 143(2):242-8. PubMed ID: 24650427
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic study of human parvovirus B19 infection in East China.
Zhang L; Cai C; Pan F; Hong L; Luo X; Hu S; Xu J; Chen Z
J Med Virol; 2016 Jul; 88(7):1113-9. PubMed ID: 26705119
[TBL] [Abstract][Full Text] [Related]
14. Infection status of human parvovirus B19, cytomegalovirus and herpes simplex Virus-1/2 in women with first-trimester spontaneous abortions in Chongqing, China.
Gao YL; Gao Z; He M; Liao P
Virol J; 2018 Apr; 15(1):74. PubMed ID: 29688863
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis.
Zajkowska A; Garkowski A; Czupryna P; Moniuszko A; Król ME; Szamatowicz J; Pancewicz S
Przegl Epidemiol; 2015; 69(3):479-82, 597-600. PubMed ID: 26519843
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.
Mor O; Ofir I; Pavel R; Bassal R; Kra-Oz Z; Cohen D; Shohat T; Mendelson E
Epidemiol Infect; 2016 Jan; 144(1):207-14. PubMed ID: 25990962
[TBL] [Abstract][Full Text] [Related]
19. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals.
Doyle S; Corcoran A
J Infect Dis; 2006 Jul; 194(2):154-8. PubMed ID: 16779720
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus B19 and low hemoglobin levels in pregnant Sudanese women.
Gasim GI; Eltayeb R; Elhassan EM; Haggaz AD; Rayis DA; Adam I
Int J Gynaecol Obstet; 2016 Mar; 132(3):318-20. PubMed ID: 26674318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
